The Global Capnography Equipment Market size is expected to reach $451.8 million by 2028, rising at a market growth of 4.6% CAGR during the forecast period.
Capnography is a technique for determining ventilation among patients and to confirm airway device. Capnograph is a waveform that measures and displays respiration rate by observing the CO2 level at each stage of the respiratory cycle. In addition, capnography devices are also known as capnographs, which are devices that measure the carbon dioxide (CO2) concentration in exhaled air. Intensive care and anesthetic procedures make heavy use of this equipment.
The rise in respiratory illness incidences, technological improvements in capnography devices, and government measures supporting the usage of capnography devices are all aspects that are positively impacting the market growth. Furthermore, the capnography market is predicted to grow due to an increase in the number of surgical procedures. Capnography devices are projected to see a jump in demand as they are used to monitor the effects of anesthetic during surgery. Surgical operations were performed in 2.7 million hospitalizations between 2016 and 2017, according to the Australian Institute of Health and Welfare. Furthermore, as the frequency of in-patient and out-patient operations rises, so will the requirement for capnography devices, propelling the capnography devices market forward.
One of the primary elements driving the industry's growth is the substantial number of people diagnosed with respiratory disorders around the world. According to an article published in the National Centre for Biotechnology Information (NCBI), the global number of lung cancer deaths is expected to double from 1.1 million cases in 2012 to 2.1 million in 2035 in the whole world. Consequently, the number of lung cancer deaths in some regions is also expected to double, including America, the Western Pacific, and Southeast Asia. This emphasizes the growing necessity for capnography tools to detect early airway problems and respiratory depression, especially during sedation, resulting in fewer serious sequelae.
Respiratory symptoms are one of the most common reasons for seeing a doctor or physician in a primary health care clinic. According to the Global Asthma Report 2018, chronic respiratory disorders affect more than 1 billion individuals worldwide. One of the key causes of the rise in respiratory ailments around the world is smoking. According to the World Health Organization, COPD, which includes tobacco smoking as its core cause, has afflicted a considerable portion of the global population.
The outbreak of the COVID-19 pandemic has impacted various domains of the business world. The key obstacles faced by healthcare systems around the world are logistical issues, monitoring patients with the disease, prioritizing patients with comorbidities and pre-existing disorders, and protecting citizens and hospital frontline staff from COVID-19 infection. To stop the illness from spreading, many hospitals have used various isolation methods. Capnometers and other capnography accessories have seen a significant surge in demand. While the scarcity of medical items became a significant problem, it also resulted in increased demand, leading to an almost tenfold rise in output.
Through ventilation monitoring or capnograph evaluation of target people, healthcare providers can detect prospective breathing difficulties at the early stage. Real-time monitoring of various respiratory parameters aids healthcare workers in deciding on treatment options for patients and enables prompt intervention when an unfavorable respiratory event occurs. Compact capnography devices are easier to handle for healthcare professionals and are useful in providing in-house care to old patients. Capnography equipment is commonly utilized in cardiology operations for patients who are sedated or anesthetized. The need for portable/point-of-care capnography equipment is estimated to rise as the number of target patients for essential applications like trauma and emergency cases grows.
The healthcare sector in developing countries presents substantial growth opportunities for key market players, driven by factors like growing target patient populations, increasing prevalence of lifestyle disorders, growing public-private investments in product development and commercialization, less stringent regulatory environments, and growing medical tourism. As of 2021, India, Saudi Arabia, France, Turkey, and Italy are among the world's fastest-growing economies. By 2023, these developing countries are estimated to account for a substantial share of overall healthcare spending.
The capnography medical equipment industry is being held back by strict and confusing regulatory standards. In the United States, proving the medical safety of a new product takes three to seven years. Even a new size of a previously approved equipment must go through the entire process before being commercialized, according to the law. When a customized product or device is developed, the corporation must go through a lengthy procedure in which each component of the item is individually examined and certified. Simple capnography equipment has received FDA certification, but sophisticated devices that must meet a slew of FDA standards are a roadblock to the widespread availability of capnography equipment. The capnography equipment market is additionally hampered by state legal constraints and manufacturing regulations.
Based on Technology, the market is segmented into Mainstream, Sidestream, and Microstream. The microstream segment garnered a significant revenue share in the capnography equipment market in 2021. Microstream technology is likely to develop steadily throughout the forecast period, owing to increased penetration of these goods as a consequence of technological developments in this industry. Furthermore, micro stream technology can be employed in both intubated and non-intubated patients, as well as patients of various ages.
Based on Application, the market is segmented into Cardiac Care, Trauma & Emergency Care, Respiratory Monitoring, and Others. The cardiac care segment acquired the largest revenue share of the capnography equipment market in 2021. The growing number of cardiopulmonary surgeries conducted around the world, combined with increasing regulatory rules advocating capnography for cardiac procedures, has resulted in a substantial growth of the segment.
Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers & Home Care, and Others. The ambulatory surgery centers & home care segment accounted for a significant revenue share in the capnography equipment market in 2021. According to the article in Health Affairs, the frequency of surgical procedures performed in ambulatory surgical facilities has increased dramatically in recent years. Furthermore, in the United States, the majority of procedures are performed in outpatient settings, as ambulatory surgery centers are a less expensive option than hospitals for outpatient surgeries. In comparison to surgeries performed in hospitals, procedures performed in these healthcare institutions take an average of 31.8 minutes.
Based on Product, the market is segmented into Accessories & disposables and Capnometers (Multiparameter and Standalone). The accessories and disposables segment acquired the largest revenue share in the capnography equipment market in 2021. The capnography accessories market is being driven by the increasing acceptance of capnography equipment, guidelines for its usage in patient monitoring, medical reimbursements for capnography equipment across developed nations, and the growing number of surgical procedures.
| Report Attribute | Details |
|---|---|
| Market size value in 2021 | USD 328.4 Million |
| Market size forecast in 2028 | USD 451.8 Million |
| Base Year | 2021 |
| Historical Period | 2018 to 2020 |
| Forecast Period | 2022 to 2028 |
| Revenue Growth Rate | CAGR of 4.6% from 2022 to 2028 |
| Number of Pages | 285 |
| Number of Tables | 520 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Technology, Product, Application, End User, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America acquired the maximum revenue share of the capnography equipment market in 2021. The high impact key driver for the regional market is the rising frequency of respiratory ailments as a result of poor lifestyles and excessive stress levels. In addition, new reimbursement methods for respiratory and monitoring solution treatments in this region, as well as strict regulatory criteria targeted at patient safety, medical efficacy, and clinical efficiency, are projected to increase product demand in the coming years.
Free Valuable Insights: Global Capnography Equipment Market size to reach USD 451.8 Million by 2028
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Masimo Corporation, Koninklijke Philips N.V., Becton, Dickinson and Company, Medtronic PLC, General Electric (GE) Co. (GE Healthcare), Dragerwerk AG & Co. KGaA, Asahi Kasei Corporation (Zoll Medical Corporation), Hamilton Medical AG (Hamilton Bonaduz AG), Edan Instruments, Inc., and Nihon Kohden Corporation.
By Technology
By Application
By End User
By Product
By Geography
The capnography equipment market size is projected to reach USD 451.8 million by 2028.
Development of compact capnography devices are driving the market in coming years, however, strict regulatory procedures for the approval of capnography equipment growth of the market.
Masimo Corporation, Koninklijke Philips N.V., Becton, Dickinson and Company, Medtronic PLC, General Electric (GE) Co. (GE Healthcare), Dragerwerk AG & Co. KGaA, Asahi Kasei Corporation (Zoll Medical Corporation), Hamilton Medical AG (Hamilton Bonaduz AG), Edan Instruments, Inc., and Nihon Kohden Corporation.
The Mainstream segment acquired maximum revenue share in the Global Capnography Equipment Market by Technology in 2021, thereby, achieving a market value of $300.5 million by 2028.
The Hospitals segment is leading the Global Capnography Equipment Market by End User in 2021, thereby, achieving a market value of $339.7 million by 2028.
The North America is the fastest growing region in the Global Capnography Equipment Market by Region in 2021, and would continue to be a dominant market till 2028.
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
